• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喹喔啉核:抗癌药物发现中一个有前景的骨架。

Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery.

作者信息

Pinheiro Alessandra C, Mendonça Nogueira Thais C, de Souza Marcus V N

机构信息

FioCruz-Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-Far-Manguinhos, Rua Sizenando Nabuco, 100, Manguinhos, 21041-250, Rio de Janeiro - RJ, Brazil.

出版信息

Anticancer Agents Med Chem. 2016;16(10):1339-52. doi: 10.2174/1871520616666160622090839.

DOI:10.2174/1871520616666160622090839
PMID:27349448
Abstract

Heterocyclic compounds are a class of substances, which play a critical role in modern drug discovery being incorporated in the structure of a large variety of drugs used in many different types of diseases. Quinoxaline is an important heterocyclic nucleus with a wide spectrum of biological activities, and recently much attention has been found on anticancer drug discovery based on this class. Owing to the importance of this system, the aim of this review is to provide an update on the synthesis and anticancer activity of quinoxaline derivatives covering articles published between 2010 and 2015.

摘要

杂环化合物是一类物质,在现代药物发现中起着关键作用,被纳入用于许多不同类型疾病的多种药物结构中。喹喔啉是一种具有广泛生物活性的重要杂环核,最近基于此类的抗癌药物发现受到了广泛关注。由于该体系的重要性,本综述的目的是提供2010年至2015年间发表的关于喹喔啉衍生物的合成及抗癌活性的文章的最新情况。

相似文献

1
Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery.喹喔啉核:抗癌药物发现中一个有前景的骨架。
Anticancer Agents Med Chem. 2016;16(10):1339-52. doi: 10.2174/1871520616666160622090839.
2
Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity.靶向酪氨酸激酶的喹喔啉类骨架及其潜在抗癌活性
Arch Pharm (Weinheim). 2016 May;349(5):309-26. doi: 10.1002/ardp.201500468. Epub 2016 Apr 9.
3
Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents.喹喔啉衍生物:抗癌药物的最新发现和研发策略。
Eur J Med Chem. 2024 May 5;271:116360. doi: 10.1016/j.ejmech.2024.116360. Epub 2024 Apr 7.
4
Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.新型喹喔啉衍生物的设计与合成及其作为抗癌药物和凋亡诱导剂的作用。
Molecules. 2019 Mar 25;24(6):1175. doi: 10.3390/molecules24061175.
5
An insight into medicinal chemistry of anticancer quinoxalines.抗癌喹喔啉类药物的化学治疗学研究进展
Bioorg Med Chem. 2019 Jan 1;27(1):16-35. doi: 10.1016/j.bmc.2018.11.021. Epub 2018 Nov 15.
6
Recent advances on quinoxalines as target-oriented chemotherapeutic anticancer agents through apoptosis.喹喔啉类化合物作为靶向化疗抗癌药物通过细胞凋亡的最新进展。
Arch Pharm (Weinheim). 2024 Sep;357(9):e2400225. doi: 10.1002/ardp.202400225. Epub 2024 May 31.
7
Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.鉴定 3-(苯并唑-2-基)喹喔啉衍生物为有效的抗癌化合物:基于结构的特权设计、合成及体内外的生物活性评估。
Eur J Med Chem. 2019 Mar 1;165:293-308. doi: 10.1016/j.ejmech.2019.01.004. Epub 2019 Jan 11.
8
Recent Methods for the Synthesis of Quinoxaline Derivatives and their Biological Activities.近期合成喹喔啉衍生物的方法及其生物活性。
Mini Rev Med Chem. 2024;24(9):920-982. doi: 10.2174/0113895575264375231012115026.
9
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.新型4-[4-(4-取代哌啶-1-基)]苄基-苯基吡咯并[1,2-a]喹喔啉羧酸乙酯衍生物在髓系和淋巴系白血病细胞系中的细胞毒性活性的合成与评价
Eur J Med Chem. 2016 May 4;113:214-27. doi: 10.1016/j.ejmech.2016.02.047. Epub 2016 Feb 20.
10
Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives.新型乙基 3-(芳基乙炔基)喹喔啉-2-羧酸酯和吡啶并[4,3-b]喹喔啉-1(2H)-酮衍生物的合成及体外增殖活性评价。
Eur J Med Chem. 2016 Nov 29;124:959-966. doi: 10.1016/j.ejmech.2016.10.025. Epub 2016 Oct 13.

引用本文的文献

1
Anticancer, anti-inflammatory and analgesic activities of aminoalcohol-based quinoxaline small molecules.基于氨基酸醇的喹喔啉小分子的抗癌、抗炎和镇痛活性。
Acta Cir Bras. 2024 Aug 5;39:e395124. doi: 10.1590/acb395124. eCollection 2024.
2
Synthesis of Morpholine-, Piperidine-, and -Substituted Piperazine-Coupled 2-(Benzimidazol-2-yl)-3-arylquinoxalines as Novel Potent Antitumor Agents.作为新型强效抗肿瘤剂的吗啉、哌啶和取代哌嗪偶联的2-(苯并咪唑-2-基)-3-芳基喹喔啉的合成
ACS Pharmacol Transl Sci. 2022 Sep 1;5(10):945-962. doi: 10.1021/acsptsci.2c00118. eCollection 2022 Oct 14.
3
Design and synthesis of new bis(1,2,4-triazolo[3,4-][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition.
通过双重抑制PARP-1和EGFR靶点设计与合成新型双(1,2,4-三唑并[3,4-b][1,3,4]噻二嗪)和双((喹喔啉-2-基)苯氧基)烷烃作为抗乳腺癌药物
RSC Adv. 2022 Aug 19;12(36):23644-23660. doi: 10.1039/d2ra03549a. eCollection 2022 Aug 16.
4
Recent advances in the transition-metal-free synthesis of quinoxalines.喹喔啉无过渡金属合成的最新进展。
RSC Adv. 2021 Nov 19;11(59):37325-37353. doi: 10.1039/d1ra06942j. eCollection 2021 Nov 17.
5
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.新型 3-甲基喹喔啉衍生物作为 VEGFR-2 抑制剂和凋亡诱导剂的设计、合成、对接、ADMET 研究和抗癌评估。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1760-1782. doi: 10.1080/14756366.2021.1956488.
6
Spectral Probe for Electron Transfer and Addition Reactions of Azide Radicals with Substituted Quinoxalin-2-Ones in Aqueous Solutions.水溶液中叠氮自由基与取代喹喔啉-2-酮的电子转移和加成反应的光谱探针。
Int J Mol Sci. 2021 Jan 10;22(2):633. doi: 10.3390/ijms22020633.
7
Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents.新型喹唑啉酮衍生物作为潜在抗癌剂的合成及细胞毒性评价
Res Pharm Sci. 2018 Oct;13(5):450-459. doi: 10.4103/1735-5362.236838.
8
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling.异吲哚酮-苯并嗪分子杂化物作为潜在的抗增殖剂:合成与体外药理学分析
Drug Des Devel Ther. 2017 Aug 9;11:2333-2346. doi: 10.2147/DDDT.S140164. eCollection 2017.